Intra-aortic balloon pump does not influence cerebral hemodynamics and neurological outcomes in high-risk cardiac patients undergoing cardiac surgery: an analysis of the IABCS trial

Carregando...
Imagem de Miniatura
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGEROPEN
Citação
ANNALS OF INTENSIVE CARE, v.9, n.1, article ID 130, 11p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background The intra-aortic balloon pump (IABP) is often used in high-risk patients undergoing cardiac surgery to improve coronary perfusion and decrease afterload. The effects of the IABP on cerebral hemodynamics are unknown. We therefore assessed the effect of the IABP on cerebral hemodynamics and on neurological complications in patients undergoing cardiac surgery who were randomized to receive or not receive preoperative IABP in the 'Intra-aortic Balloon Counterpulsation in Patients Undergoing Cardiac Surgery' (IABCS) trial. Methods This is a prospectively planned analysis of the previously published IABCS trial. Patients undergoing elective coronary artery bypass surgery with ventricular ejection fraction <= 40% or EuroSCORE >= 6 received preoperative IABP (n = 90) or no IABP (n = 91). Cerebral blood flow velocity (CBFV) of the middle cerebral artery through transcranial Doppler and blood pressure through Finometer or intra-arterial line were recorded preoperatively (T1) and 24 h (T2) and 7 days after surgery (T3) in patients with preoperative IABP (n = 34) and without IABP (n = 33). Cerebral autoregulation was assessed by the autoregulation index that was estimated from the CBFV response to a step change in blood pressure derived by transfer function analysis. Delirium, stroke and cognitive decline 6 months after surgery were recorded. Results There were no differences between the IABP and control patients in the autoregulation index (T1: 5.5 +/- 1.9 vs. 5.7 +/- 1.7; T2: 4.0 +/- 1.9 vs. 4.1 +/- 1.6; T3: 5.7 +/- 2.0 vs. 5.7 +/- 1.6, p = 0.97) or CBFV (T1: 57.3 +/- 19.4 vs. 59.3 +/- 11.8; T2: 74.0 +/- 21.6 vs. 74.7 +/- 17.5; T3: 71.1 +/- 21.3 vs. 68.1 +/- 15.1 cm/s; p = 0.952) at all time points. Groups were not different regarding postoperative rates of delirium (26.5% vs. 24.2%, p = 0.83), stroke (3.0% vs. 2.9%, p = 1.00) or cognitive decline through analysis of the Mini-Mental State Examination (16.7% vs. 40.7%; p = 0.07) and Montreal Cognitive Assessment (79.16% vs. 81.5%; p = 1.00). Conclusions The preoperative use of the IABP in high-risk patients undergoing cardiac surgery did not affect cerebral hemodynamics and was not associated with a higher incidence of neurological complications. Trial registration (NCT02143544).
Palavras-chave
IABP, Transcranial Doppler, Cerebral autoregulation, Cardiopulmonary bypass
Referências
  1. Appelboom G, 2010, NEUROCRIT CARE, V13, P385, DOI 10.1007/s12028-010-9442-2
  2. Baskett RJF, 2002, ANN THORAC SURG, V74, P1276, DOI 10.1016/S0003-4975(02)03663-9
  3. Beholz S, 1998, ANN THORAC SURG, V65, P603
  4. Bellapart J, 2010, BMC ANESTHESIOL, V10, DOI 10.1186/1471-2253-10-3
  5. BRASS LM, 1990, STROKE, V21, P484, DOI 10.1161/01.STR.21.3.484
  6. Caldas JR, 2017, PHYSIOL MEAS, V38, P1349, DOI 10.1088/1361-6579/aa68c4
  7. Caldas JR, 2018, INTERACT CARDIOV TH, V26, P494, DOI 10.1093/icvts/ivx357
  8. Cavallazzi R, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-49
  9. Cheung AT, 1998, J CARDIOTHOR VASC AN, V12, P51, DOI 10.1016/S1053-0770(98)90055-6
  10. Claassen JAHR, 2016, J CEREBR BLOOD F MET, V36, P665, DOI 10.1177/0271678X15626425
  11. Cropsey C, 2015, SEMIN CARDIOTHORAC V, V19, P309, DOI 10.1177/1089253215570062
  12. Cruz-Flores S, 2005, NEUROCRIT CARE, V2, P49, DOI 10.1385/NCC:2:1:049
  13. de Riva N, 2012, NEUROCRIT CARE, V17, P58, DOI 10.1007/s12028-012-9672-6
  14. Ducruet AF, 2013, WORLD NEUROSURG, V80, pE347, DOI 10.1016/j.wneu.2012.05.029
  15. DUNKMAN WB, 1972, CIRCULATION, V46, P465, DOI 10.1161/01.CIR.46.3.465
  16. Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703
  17. FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
  18. Glick REL, 1996, J GERIATR PSYCH NEUR, V9, P97, DOI 10.1177/089198879600900205
  19. Gosling RG, 2003, HYPERTENSION, V41, P1180, DOI 10.1161/01.HYP.0000072271.36866.2A
  20. HONET JC, 1975, ARCH PHYS MED REHAB, V56, P346
  21. Inouye SK, 2001, ARCH INTERN MED, V161, P2467, DOI 10.1001/archinte.161.20.2467
  22. INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941
  23. Koster S, 2011, EUR J CARDIOVASC NUR, V10, P197, DOI 10.1016/j.ejcnurse.2010.09.001
  24. Kunt A, 2013, J CARDIOVASC SURG, V54, P537
  25. Morgalla MH, 2016, J CLIN ULTRASOUND, V44, P40, DOI 10.1002/jcu.22279
  26. MOULOPOULOS SD, 1962, AM HEART J, V63, P669, DOI 10.1016/0002-8703(62)90012-1
  27. Mullges W, 2000, CRIT CARE MED, V28, P1808, DOI 10.1097/00003246-200006000-00020
  28. MURKIN JM, 1995, ANN THORAC SURG, V59, P1289, DOI 10.1016/0003-4975(95)00106-U
  29. Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x
  30. Newman MF, 2001, STROKE, V32, P2874, DOI 10.1161/hs1201.099803
  31. Ono M, 2013, CRIT CARE MED, V41, P464, DOI 10.1097/CCM.0b013e31826ab3a1
  32. Ono M, 2013, ANESTH ANALG, V116, P198, DOI 10.1213/ANE.0b013e318271fb10
  33. Panerai RB, 2016, PHYSIOL MEAS, V37, P661, DOI 10.1088/0967-3334/37/5/661
  34. Panerai RB, 1998, STROKE, V29, P2341, DOI 10.1161/01.STR.29.11.2341
  35. Patel N, 2019, STROKE, V50, P336, DOI 10.1161/STROKEAHA.118.023355
  36. Patel N, 2016, PHYSIOL MEAS, V37, P1485, DOI 10.1088/0967-3334/37/9/1485
  37. Petroni T, 2014, CRIT CARE MED, V42, P2075, DOI 10.1097/CCM.0000000000000410
  38. Pfluecke C, 2014, PERFUSION-UK, V29, P511, DOI 10.1177/0267659114525218
  39. Ringelstein EB, 1986, TRANSCRANIAL DOPPLER, P147
  40. Ferreira GSR, 2018, CRIT CARE MED, V46, pE742, DOI 10.1097/CCM.0000000000003185
  41. Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923
  42. Salazar JD, 2001, ANN THORAC SURG, V72, P1195, DOI 10.1016/S0003-4975(01)02929-0
  43. Sammons EL, 2007, J APPL PHYSIOL, V103, P369, DOI 10.1152/japplphysiol.00271.2007
  44. Schachtrupp A, 2005, EUR J ANAESTH, V22, P165, DOI 10.1017/S0265021505000293
  45. Scolletta S, 2015, MINERVA ANESTESIOL, V81, P662
  46. Selnes OA, 2003, ANN THORAC SURG, V75, P1377, DOI 10.1016/S0003-4975(03)00021-3
  47. Selnes OA, 2012, NEW ENGL J MED, V366, P250, DOI 10.1056/NEJMra1100109
  48. Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672
  49. TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014
  50. Trabold B, 2014, J CARDIOTHOR VASC AN, V28, P1352, DOI 10.1053/j.jvca.2014.03.017
  51. Voulgaris SG, 2005, MED SCI MONITOR, V11, pCR49
  52. WEBER KT, 1974, ANN THORAC SURG, V17, P602, DOI 10.1016/S0003-4975(10)65706-2
  53. Yang F, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-106
  54. Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42